Efficacy and safety of Yijin-tang on polycystic ovarian syndrome: A single-arm pilot study
Not Applicable
Completed
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0002749
- Lead Sponsor
- Kyung Hee University Oriental Medicine Hospital at Gangdong
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 15
Inclusion Criteria
(1) diagnosis of PCOS
(2) oligomenorrhea
(3) 18–43 years of age
(4) overweight with body mass index (BMI) = 23 kg/m2
(5) diagnosis of phlegm by phlegm pattern questionnaire
Exclusion Criteria
(1) pregnancy or breastfeeding within the past 12 weeks
(2) intake of oral contraceptive or ovulation inducing agent within the past 8 weeks
(3) severe oligomenorrhea with menstrual period over 3 months within the past one year
(4) endocrine disorders (thyroid disease, Cushing’s disease, or hyperprolactinemia) that influence hormone levels
(5) ovarian tumor or adrenal tumor that can induce hyperadrogenemia
(6) severe cardiac, pulmonary, hepatic, and renal diseases
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method menstrual period
- Secondary Outcome Measures
Name Time Method The levels of estradiol;The level of leuteinizing hormone (LH),;The level of follicle stimulating hormone (FSH),;The level of free testosterone;LH/FSH ratio;follicle number of the ovary;phlegm pattern questionnaire scores;body weight, body mass index(BMI)